Calcichew-D3 Forte 500 mg+10 mikrogram tyggetabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

calcichew-d3 forte 500 mg+10 mikrogram tyggetabletter

abacus medicine a/s - calciumcarbonat, cholecalciferol - tyggetabletter - 500 mg+10 mikrogram

Calcichew-D3 Forte 500 mg+10 mikrogram tyggetabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

calcichew-d3 forte 500 mg+10 mikrogram tyggetabletter

2care4 aps - calciumcarbonat, cholecalciferol - tyggetabletter - 500 mg+10 mikrogram

Calcigran Forte 500 mg+10 mikrogram tyggetabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

calcigran forte 500 mg+10 mikrogram tyggetabletter

abacus medicine a/s - calciumcarbonat, cholecalciferol - tyggetabletter - 500 mg+10 mikrogram

Tevimbra Den Europæiske Union - dansk - EMA (European Medicines Agency)

tevimbra

novartis europharm limited - tislelizumab - esophageal squamous cell carcinoma - antineoplastiske midler - oesophageal squamous cell carcinoma (oscc) tevimbra as monotherapy is indicated for the treatment of adult patients with unresectable, locally advanced or metastatic oesophageal squamous cell carcinoma after prior platinum-based chemotherapy.

Mydrane 0,2+3,1+10 mg/ml injektionsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

mydrane 0,2+3,1+10 mg/ml injektionsvæske, opløsning

laboratoires thea s.a.s. - lidocainhydrochloridmonohydrat, phenylephrinhydrochlorid, tropicamid - injektionsvæske, opløsning - 0,2+3,1+10 mg/ml

Gaviscon oral suspension Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

gaviscon oral suspension

nordic drugs ab - aluminiumhydroxidgel, calciumcarbonat, natriumalginat, natriumhydrogencarbonat - oral suspension

Gaviscon tyggetabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

gaviscon tyggetabletter

nordic drugs ab - alginsyre, aluminiumhydroxid, natriumhydrogencarbonat - tyggetabletter